HJR 8-OPPOSE GENETICALLY ENGINEERED SALMON  2:58:54 PM CO-CHAIR SEATON announced that the next order of business is HOUSE JOINT RESOLUTION NO. 8, Urging the United States Food and Drug Administration to deny an application to sell genetically engineered salmon in the United States; urging compliance with the provision of P.L. 110-85 (Food and Drug Administration Amendments Act of 2007) that requires the Commissioner of Food and Drugs to consult with the National Marine Fisheries Service of the National Oceanic and Atmospheric Administration regarding a report on environmental risks associated with genetically engineered seafood products; and urging that product labeling requirements include the words "Genetically Modified" prominently displayed on the front of the package if the application is approved by the United States Food and Drug Administration. [Before the committee was CSHJR 8(FSH).] 3:00:07 PM REPRESENTATIVE KAWASAKI, speaking as the sponsor HJR 8, explained that the resolution is a statement to the U.S. Food and Drug Administration (FDA) and Congress that urges the FDA to deny the application before it to sell genetically engineered salmon. There is a proposal from a company for a hybrid Atlantic salmon, which could be the first genetically engineered animal for human consumption in the U.S. He opined that there hasn't been enough due diligence at the FDA and it would establish a risky precedence to allow the sale of these genetically modified salmon. He reminded the committee of the farmed fin fish from British Columbia, Canada, that have traveled into Alaskan waters. There is no knowledge regarding what will happen with this genetically modified salmon, which is an Atlantic salmon with the growth genes of a king salmon and an anti-freeze gene of an eel. He characterized this salmon as "frankenfish" and stressed that science needs to be done before approving it as food for human consumption. He noted that Representative Herron offered an amendment in the House Special Committee on Fisheries that the committee was unable to address, but which could be considered in this committee. 3:00:39 PM CO-CHAIR SEATON announced that HJR 8 would be held over.